Sailong Pharmaceutical Group Co Ltd Class A 002898
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 10.08
- Day Range
- CNY 9.98–10.17
- 52-Week Range
- CNY 7.70–20.02
- Bid/Ask
- CNY 10.12 / CNY 10.13
- Market Cap
- CNY 1.78 Bil
- Volume/Avg
- 3.4 Mil / 8.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.93
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 464
- Website
- http://www.sailong.cn
Comparables
Valuation
|
Metric
|
002898
|
605177
|
300194
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 31.18 | 16.94 |
Price/Book Value | 3.31 | 1.49 | 1.16 |
Price/Sales | 5.93 | 2.47 | 1.84 |
Price/Cash Flow | 74.81 | — | 9.25 |
Price/Earnings
002898
605177
300194
Financial Strength
|
Metric
|
002898
|
605177
|
300194
|
|---|---|---|---|
Quick Ratio | 0.58 | 1.49 | 1.18 |
Current Ratio | 1.04 | 2.49 | 1.77 |
Interest Coverage | −1.91 | 34.61 | 10.96 |
Quick Ratio
002898
605177
300194
Profitability
|
Metric
|
002898
|
605177
|
300194
|
|---|---|---|---|
Return on Assets (Normalized) | −0.31% | 3.47% | 0.94% |
Return on Equity (Normalized) | −0.47% | 5.40% | 1.40% |
Return on Invested Capital (Normalized) | 0.41% | 3.92% | 1.12% |
Return on Assets
002898
605177
300194
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qprzvmfytz | Hxgd | $545.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gydtmxskm | Chksd | $105.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qbdbxvtpq | Rvrxby | $103.7 Bil | |
MRNA
| Moderna Inc | Vhnxgnx | Tlj | $47.9 Bil | |
ARGX
| argenx SE ADR | Zdzwfwx | Cgbm | $22.9 Bil | |
BNTX
| BioNTech SE ADR | Pcfcbcmm | Lzb | $22.3 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Pjgqbzxn | Fzhdcxd | $19.3 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bxbbkqf | Zbztcq | $15.7 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fgqpvnrvk | Myppbym | $12.8 Bil | |
INCY
| Incyte Corp | Gprsnsgmx | Jrkdqtt | $12.1 Bil |